Joint Statement by Six Parkinson's Disease Organizations Regarding Proposed Label Change for Azilect submitted to FDA Advisory Committee Meeting on 10-17-11

Share

This statement is prepared on behalf of the American Parkinson Disease Association, The Michael J. Fox Foundation for Parkinson’s Research, the National Parkinson Foundation, the Parkinson’s Action Network, the Parkinson Alliance, and the Parkinson’s Disease Foundation.  Click here to read the PDF.

Click for a printer friendly version

Back to top